The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 10, 2017

Filed:

Dec. 15, 2014
Applicant:

Fujimoto Co., Ltd., Osaka, JP;

Inventors:

Hiroko Togashi, Hokkaido, JP;

Sachiko Hiraide, Hokkaido, JP;

Fumio Yoneda, Osaka, JP;

Kazue Takahata, Osaka, JP;

Assignee:

FUJIMOTO CO., LTD., OSAKA, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/00 (2006.01); C07D 307/00 (2006.01); A61K 31/343 (2006.01); A61K 31/137 (2006.01); A61K 31/165 (2006.01); A61K 31/4168 (2006.01); A61K 31/4458 (2006.01); A61K 45/06 (2006.01); A61K 31/138 (2006.01);
U.S. Cl.
CPC ...
A61K 31/343 (2013.01); A61K 31/137 (2013.01); A61K 31/138 (2013.01); A61K 31/165 (2013.01); A61K 31/4168 (2013.01); A61K 31/4458 (2013.01); A61K 45/06 (2013.01);
Abstract

It is already known that 1-(benzofuran-2-yl)-2-propylaminopentane or a pharmacologically acceptable acid addition salt thereof exhibits an excellent effect as an antidepressant, a psychotropic drug, an antiparkinsonian drug, and an anti-Alzheimer's disease drug. However, it has not been known at all that the compound is effective for the prevention or therapy of attention-deficit/hyperactivity disorder (ADHD). The present invention has newly found that 1-(benzofuran-2-yl)-2-propylaminopentane or a pharmacologically acceptable acid addition salt thereof is effective for the prevention or therapy of ADHD, and has been accomplished.


Find Patent Forward Citations

Loading…